Vitrolife AB (publ)

OM:VITR Stock Report

Market Cap: SEK 30.0b

Vitrolife Management

Management criteria checks 2/4

Vitrolife's CEO is Bronwyn Brophy O´Connor, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is SEK7.44M, comprised of 74.5% salary and 25.5% bonuses, including company stock and options. directly owns 0.014% of the company’s shares, worth SEK4.28M. The average tenure of the management team and the board of directors is 1.3 years and 6.8 years respectively.

Key information

Bronwyn Brophy O´Connor

Chief executive officer

SEK 7.4m

Total compensation

CEO salary percentage74.5%
CEO tenure1.3yrs
CEO ownership0.01%
Management average tenure1.3yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Aug 21
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Jul 20
Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Jul 18
Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Jan 05
Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Dec 15
Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 06
Is Vitrolife (STO:VITR) A Risky Investment?

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03
Vitrolife (STO:VITR) Could Easily Take On More Debt

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26
Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23
Is Vitrolife (STO:VITR) A Risky Investment?

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18
Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09
Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07
Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Mar 31
Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Feb 07
Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

CEO Compensation Analysis

How has Bronwyn Brophy O´Connor's remuneration changed compared to Vitrolife's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 4b

Jun 30 2024n/an/a

-SEK 4b

Mar 31 2024n/an/a

-SEK 4b

Dec 31 2023SEK 7mSEK 6m

-SEK 4b

Compensation vs Market: Bronwyn's total compensation ($USD672.14K) is below average for companies of similar size in the Swedish market ($USD1.00M).

Compensation vs Earnings: Insufficient data to compare Bronwyn's compensation with company performance.

CEO

Bronwyn Brophy O´Connor (50 yo)

1.3yrs

Tenure

SEK 7,439,000

Compensation

Ms. Bronwyn Brophy O´Connor is President and Chief Executive Officer at Vitrolife AB (publ) since joining from August 01, 2023. She has an impressive track record as a leader of global Life science and Med...

Leadership Team

NamePositionTenureCompensationOwnership
Bronwyn Brophy O´Connor
CEO & President1.3yrsSEK 7.44m0.014%
SEK 4.3m
Patrik Tolf
Chief Financial Officer2.8yrsno data0.0096%
SEK 2.9m
Claus Bisgaard
Senior Vice President of Technologiesno datano data0.00028%
SEK 83.9k
Guillermo Ferrando
Vice President Strategy & Corporate development1.8yrsno datano data
Olivia Natens
Senior Vice President of Sales & Marketingless than a yearno datano data
Frank Pettersson
Acting Senior Vice President of HR & Sustainability1.1yrsno data0.0013%
SEK 392.7k
Rickard Ericsson
Senior Vice President of Consumablesless than a yearno data0.0061%
SEK 1.8m
Ricardo Capella
Senior Vice President Genetic Services2.8yrsno data0.0044%
SEK 1.3m

1.3yrs

Average Tenure

53.5yo

Average Age

Experienced Management: VITR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Henrik Blomquist
Director5.5yrsSEK 883.00k0.0081%
SEK 2.4m
Jon Sigurdsson
Chairman of the Board9.8yrsSEK 16.30m0.022%
SEK 6.7m
Lars Holmqvist
Independent Director6.8yrsSEK 450.00kno data
Pia Marions
Independent Director11.6yrsSEK 500.00k0.0037%
SEK 1.1m
Karen Soerensen
Independent Director4.4yrsSEK 500.00kno data

6.8yrs

Average Tenure

62yo

Average Age

Experienced Board: VITR's board of directors are considered experienced (6.8 years average tenure).